Physician

Hemraj R. Makwana, MD

According to 2025 Medicare claims, Hemraj Makwana, MD (NPI: 1245214196) practices cardiology in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is LIMA MEMORIAL PROFESSIONAL CORPORATION (NPI: 1457474900; TIN: 341935236) and primary practice location at 45804-2800. Makwana is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), CHSPSC ACO 21, LLC (ACO ID: A3698), and AdvantagePoint Health Alliance - Bluegrass, LLC (ACO ID: A5028), participating under the MSSP model.

Makwana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 813 traditional Medicare patients, billed 2,244 HCPCS/CPT codes, and received $133,506 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,371 prescription claims across 384 beneficiaries totaling $392,608 in drug costs, led by Entresto (Sacubitril/Valsartan). 2021 DME data shows 19 claims. Open Payments data shows 32 records totaling $772. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $176,010 and ending at $392,608. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $22,720 to $10,852.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,085	2,379	$150,106
2016	1,805	3,829	$186,838
2017	1,815	3,763	$206,964
2018	1,346	2,899	$189,196
2019	2,140	5,010	$242,068
2020	1,987	4,732	$234,342
2021	1,418	2,865	$130,988
2022	1,242	2,619	$111,632
2023	1,364	2,988	$114,728
2024	813	2,244	$133,506

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	484	3,020	$176,010
2016	509	3,657	$213,629
2017	655	4,661	$321,451
2018	571	4,400	$318,024
2019	359	2,037	$116,028
2020	291	2,729	$185,352
2021	287	1,958	$174,937
2022	162	1,167	$185,975
2023	217	1,585	$312,350
2024	384	2,371	$392,608

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$21,914
2016	N/R	12	$24,478
2017	N/R	31	$59,319
2018	N/R	27	$54,997
2019	N/R	25	$54,267
2020	13	39	$84,503
2021	N/R	19	$36,936
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	206	331	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	130	210	$59
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	202	205	$44
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	103	108	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	327	425	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	119	5,241	$114,697
Eliquis	Apixaban	121	5,317	$100,811
Farxiga	Dapagliflozin Propanediol	110	5,070	$91,909
Brilinta	Ticagrelor	44	2,250	$33,045
Xarelto	Rivaroxaban	12	354	$6,584

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$772	ABIOMED
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hemraj R. Makwana, MD?

Tedicare shows public-source Medicare data for Hemraj R. Makwana, MD (NPI 1245214196), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hemraj R. Makwana, MD have ACO affiliation data?

Hemraj R. Makwana, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215), CHSPSC ACO 21, LLC (MSSP, ACO ID A3698), and AdvantagePoint Health Alliance - Bluegrass, LLC (MSSP, ACO ID A5028).

What billing organization is linked to Hemraj R. Makwana, MD?

Hemraj R. Makwana, MD is linked to LIMA MEMORIAL PROFESSIONAL CORPORATION (billing NPI 1457474900) in the available physician profile data.

Does Hemraj R. Makwana, MD have Open Payments data?

Hemraj R. Makwana, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.